Effect of One-Year Subcutaneous and Sublingual Immunotherapy on Clinical and Laboratory Parameters in Children with Rhinitis and Asthma: A Randomized, Placebo-Controlled, Double-Blind, Double-Dummy Study-Reference-Cited by-同舟云学术

Effect of One-Year Subcutaneous and Sublingual Immunotherapy on Clinical and Laboratory Parameters in Children with Rhinitis and Asthma: A Randomized, Placebo-Controlled, Double-Blind, Double-Dummy Study

Published:2012 Issue:3 Volume:157 Page:288-298
ISSN:1423-0097
Container-title:International Archives of Allergy and Immunology
language:en
Short-container-title:Int Arch Allergy Immunol

Author:

Yukselen Ayfer,Kendirli Seval Güneser,Yilmaz Mustafa,Altintas Derya Ufuk,Karakoc Gulbin Bingol

Publisher

S. Karger AG

Subject

Immunology,General Medicine,Immunology and Allergy

Reference46 articles.

1. Allergen immunotherapy: Therapeutic vaccines for allergic diseases A WHO position paper☆☆☆★★★♢

2. Immunotherapy with a standardized extract. VI. Specific immunotherapy prevents the onset of new sensitizations in children

3. Immunotherapy with partially purified and standardized tree pollen extracts. IV. Results from long-term (6-year) follow-up

4. Pollen immunotherapy reduces the development of asthma in children with seasonal rhinoconjunctivitis (the PAT-study)

Cited by 146 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and safety of subcutaneous and sublingual allergen immunotherapy in the treatment of asthma in children: a systematic review and meta-analysis;Journal of Asthma;2024-08-28

2. Prise en charge thérapeutique et adaptation du traitement de fond;Revue des Maladies Respiratoires;2024-08

3. The evidence for commercial house dust mite immunotherapy products: A pragmatic systematic review with narrative synthesis;Journal of Allergy and Clinical Immunology: Global;2024-08

4. Allergen Immunotherapy: The Evidence Supporting the Efficacy and Safety of Subcutaneous Immunotherapy and Sublingual Forms of Immunotherapy for Allergic Rhinitis/Conjunctivitis and Asthma;The Journal of Allergy and Clinical Immunology: In Practice;2024-06

5. The safety and tolerability of a one strength dose-escalation scheme for subcutaneous immunotherapy with a native house dust mite extract in Chinese children: A multicenter, randomized, open label clinical trial;Heliyon;2024-04